Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02414555Phase 4Terminated
A Phase 4 trial of Elo-Mel Isoton in hypotension, sponsored by Medical University of Vienna. Started Mar 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02414555.